Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk

Circulation. 2001 Apr 17;103(15):1930-2. doi: 10.1161/01.cir.103.15.1930.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Antibodies, Monoclonal / metabolism
  • Arteriosclerosis / etiology
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / pathology
  • Coronary Disease / blood*
  • Coronary Disease / etiology*
  • Disease Progression
  • Epitopes / immunology
  • Humans
  • Lipoproteins, LDL / adverse effects*
  • Lipoproteins, LDL / blood*
  • Lipoproteins, LDL / immunology
  • Oxidation-Reduction
  • Predictive Value of Tests
  • Risk Assessment

Substances

  • Antibodies, Monoclonal
  • Epitopes
  • Lipoproteins, LDL
  • oxidized low density lipoprotein